Hester Biosciences Limited

NSE HESTERBIO.NS

Hester Biosciences Limited Price to Sales Ratio (P/S) on February 06, 2025: 5.09

Hester Biosciences Limited Price to Sales Ratio (P/S) is 5.09 on February 06, 2025, a 12.33% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Hester Biosciences Limited 52-week high Price to Sales Ratio (P/S) is 8.67 on July 31, 2024, which is 70.42% above the current Price to Sales Ratio (P/S).
  • Hester Biosciences Limited 52-week low Price to Sales Ratio (P/S) is 3.58 on June 04, 2024, which is -29.64% below the current Price to Sales Ratio (P/S).
  • Hester Biosciences Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 5.71.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
SV Wall Street
NSE: HESTERBIO.NS

Hester Biosciences Limited

CEO Mr. Rajiv Dinesh Gandhi B.Com
IPO Date March 13, 2015
Location India
Headquarters Pushpak
Employees 642
Sector Consumers Staples
Industries
Description

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

Similar companies

JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

USD 19.59

-0.12%

SHILPAMED.NS

Shilpa Medicare Limited

USD 8.59

1.52%

CAPLIPOINT.NS

Caplin Point Laboratories Limited

USD 24.85

-1.27%

NEULANDLAB.NS

Neuland Laboratories Limited

USD 165.33

-2.52%

ERIS.NS

Eris Lifesciences Limited

USD 16.59

4.28%

StockViz Staff

February 8, 2025

Any question? Send us an email